Related Experiment Video

Updated: Aug 17, 2026

Use of Ultra-high Field MRI in Small Rodent Models of Polycystic Kidney Disease for In Vivo Phenotyping and Drug Monitoring
07:35

Use of Ultra-high Field MRI in Small Rodent Models of Polycystic Kidney Disease for In Vivo Phenotyping and Drug Monitoring

Published on: June 23, 2015

Kidney aging: from phenotype to genetics

Michele Buemi1, Lorena Nostro, Carmela Aloisi

  • 1Department of Internal Medicine, University of Messina, Messina, Italy. buemim@unime.it

Rejuvenation Research
|June 3, 2005
PubMed

Insights

Physiological aging causes kidney structure and function changes in elderly individuals. Further research into molecular mechanisms like oxidative stress and telomere length is needed to understand and treat kidney aging.

Area of Science:

  • Gerontology
  • Nephrology
  • Molecular Biology

Background:

  • Aging is a natural physiological process leading to structural and functional decline in body systems, including the kidneys.
  • Kidney function in the elderly can be affected by genetic factors, environmental agents, and comorbidities like atherosclerosis and hypertension.
  • The inevitability and rate of renal function decline solely due to physiological aging remain unclear.

Purpose of the Study:

  • To explore the molecular mechanisms underlying kidney tissue damage during aging.
  • To investigate the impact of aging on renal function and identify potential intervention points.
  • To enhance the clinical management and therapeutic options for kidney aging and transplantation.

Main Methods:

  • Review of current literature on physiological aging and kidney function.
  • Analysis of molecular pathways implicated in age-related kidney damage.
  • Exploration of the roles of nitric oxide, oxidative stress, renin-angiotensin system, telomere length, and klotho gene expression.

Main Results:

  • Aging involves structural and functional changes in the kidneys, potentially leading to organ failure.
  • Comorbidities significantly impact the kidney's ability to adapt to age-related structural changes.
  • Specific molecular mechanisms require further in-depth investigation.

Conclusions:

  • Understanding the molecular basis of kidney aging is crucial for developing targeted interventions.
  • Improved knowledge of physiological renal aging can refine clinical approaches and expand transplantation possibilities.
  • Further research into key molecular players is essential for addressing age-related kidney decline.

More Related Videos

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging09:37

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging

Published on: July 14, 2016

Related Concept Videos

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
Nephrons01:10

Nephrons

The kidneys are intricate organs with millions of working units known as nephrons. Each nephron features two major structures: the renal corpuscle, which facilitates blood plasma filtration, and the renal tubule, which handles the glomerular filtrate. Blood supply is directly linked to the nephrons. The renal corpuscle consists of the glomerulus, a capillary network, and the Bowman's capsule, a double-walled epithelial structure that encases the glomerulus. The filtering of blood plasma happens...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption01:22

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...